# PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
> **ANDA204982** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2024-06-25
## Drug
- **FDA Application Number:** ANDA204982
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
- **Generic name:** PHENTERMINE AND TOPIRAMATE
- **Active ingredients:** PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS LABS FL INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2024-06-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204982)
---
*MORVS · CC0 1.0*